Targeting gut microbiota could improve insulin sensitivity (Udayappan et al., 2016), thereby regulating insulin-mediated lipid metabolism in adipocytes (Kimura et al., 2013) and improving host obesity. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.